Prediction: D-Wave Quantum's Revenue Triples Before 2030

D-Wave Quantum's first-half 2026 revenue fell 67% year over year to $5.9 million, reflecting difficult comparisons against a $12.6 million system sale in Q1 2025, while Q2 revenue was nearly flat at $3.1 million. However, first-half bookings surged to $35.5 million from $2.9 million and remaining performance obligations reached $40.7 million, with 57% expected to convert into revenue within 12 months. The company has $550 million in cash and marketable securities plus access to up to $100 million in CHIPS Act R&D funding, but its $6.6 billion valuation would still equate to roughly 90x sales even if revenue triples to about $74 million by 2029.

Analysis

QBTS is transitioning from an option on quantum adoption to a concentrated project-delivery story, which creates a misleadingly favorable bookings narrative. A small number of large contracts can produce sharp reported-revenue step-ups, but acceptance milestones, installation delays, customer financing terms, and any performance shortfall can defer recognition by multiple quarters. With operating costs materially above recurring revenue, the relevant valuation variable is not backlog conversion alone but whether cloud usage expands enough to reduce dependence on irregular hardware sales.

The Commerce Department arrangement reduces near-term financing risk but introduces a non-economic stakeholder and likely dilution/terms uncertainty. Federal support also raises the strategic value of U.S.-based quantum supply chains: SKYT could benefit indirectly if domestic quantum programs require secure fabrication capacity, although the magnitude depends on D-Wave's manufacturing sourcing and award disbursement conditions. IONQ remains the cleaner relative long because its revenue base has greater near-term scale and acquisition-driven visibility, but its own multiple leaves the sector vulnerable to a broad de-rating if commercialization timelines slip.

Near term, QBTS can rally on installation milestones or additional system orders because the float is likely driven by narrative and retail momentum rather than earnings power. Over 1-3 months, investors should focus on conversion of contracted obligations into cash and revenue, gross margin on system delivery, and whether operating-expense growth decelerates. Over 6-18 months, the key falsifier for the bearish valuation view is repeatable cloud growth and multiple non-government, multi-year enterprise renewals that establish a durable recurring-revenue mix rather than one-off equipment demand.

Consensus may underappreciate that a large backlog is not equivalent to product-market fit when it is dominated by two customers. Conversely, outright shorting QBTS carries substantial squeeze risk from government-funding headlines and new contract announcements; the better expression is relative valuation rather than directional exposure.

Key Decisions for Investors

• Avoid initiating a core QBTS long at current valuation; reassess only after two consecutive quarters of backlog conversion with cloud/recurring revenue growth exceeding operating-expense growth. A material delay in the first major installation or sub-50% 12-month conversion of contracted obligations would reinforce downside risk.
• Establish a 1-3 month relative-value position: long IONQ / short QBTS in equal dollar amounts, entered after QBTS strength on funding or contract headlines. The thesis is superior revenue scale and visibility at IONQ versus QBTS's concentrated delivery risk; cover if QBTS announces a second comparably sized commercial system order or demonstrates recurring cloud acceleration.
• For holders seeking downside protection rather than a short, use QBTS put spreads 3-6 months out, sized modestly given high implied volatility. Target a structure that benefits from a 25-35% retracement; the principal risk is a momentum squeeze around government awards, delivery announcements, or sector-wide quantum enthusiasm.
• Monitor SKYT for disclosed quantum-related design wins, fabrication commitments, or CHIPS-linked capacity awards before treating D-Wave as a meaningful earnings catalyst. Without quantified customer exposure, any sympathy move in SKYT is a watch item, not a standalone trade.